Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2007 2
2010 2
2011 2
2012 1
2013 4
2014 2
2015 4
2016 8
2017 7
2018 4
2019 6
2020 8
2021 7
2022 8
2023 10
2024 18
2025 12
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lestini b (19 results)?
A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.
Kramvis A, Chang KM, Dandri M, Farci P, Glebe D, Hu J, Janssen HLA, Lau DTY, Penicaud C, Pollicino T, Testoni B, Van Bömmel F, Andrisani O, Beumont-Mauviel M, Block TM, Chan HLY, Cloherty GA, Delaney WE, Geretti AM, Gehring A, Jackson K, Lenz O, Maini MK, Miller V, Protzer U, Yang JC, Yuen MF, Zoulim F, Revill PA. Kramvis A, et al. Among authors: testoni b. Nat Rev Gastroenterol Hepatol. 2022 Nov;19(11):727-745. doi: 10.1038/s41575-022-00649-z. Epub 2022 Jul 20. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35859026 Free PMC article. Review.
Hepatitis B.
Zoulim F, Levrero M, Testoni B. Zoulim F, et al. Among authors: testoni b. Nat Rev Gastroenterol Hepatol. 2018 Sep 20. doi: 10.1038/s41575-018-0060-3. Online ahead of print. Nat Rev Gastroenterol Hepatol. 2018. PMID: 30237516 No abstract available.
Eliminating cccDNA to cure hepatitis B virus infection.
Zoulim F, Testoni B. Zoulim F, et al. Among authors: testoni b. J Hepatol. 2023 Apr;78(4):677-680. doi: 10.1016/j.jhep.2023.01.017. Epub 2023 Jan 27. J Hepatol. 2023. PMID: 36717025 No abstract available.
Virology special issue: Hepatitis B.
Tu T, Verrier ER, Testoni B. Tu T, et al. Among authors: testoni b. Virology. 2025 Sep;610:110550. doi: 10.1016/j.virol.2025.110550. Epub 2025 May 15. Virology. 2025. PMID: 40450392 No abstract available.
TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.
Roca Suarez AA, Plissonnier ML, Grand X, Michelet M, Giraud G, Saez-Palma M, Dubois A, Heintz S, Diederichs A, Van Renne N, Vanwolleghem T, Daffis S, Li L, Kolhatkar N, Hsu YC, Wallin JJ, Lau AH, Fletcher SP, Rivoire M, Levrero M, Testoni B, Zoulim F. Roca Suarez AA, et al. Among authors: testoni b. Gut. 2024 Nov 11;73(12):2012-2022. doi: 10.1136/gutjnl-2023-331396. Gut. 2024. PMID: 38697771 Free PMC article.
Scientific and medical evidence informing expansion of hepatitis B treatment guidelines.
Kennedy PT, Allweiss L, Bertoletti A, Cornberg M, Gehring AJ, Guidotti LG, Kerth HA, Lemoine M, Levrero M, Lim SG, Tavis JE, Testoni B, Tu T; International Coalition to Eliminate HBV. Kennedy PT, et al. Among authors: testoni b. Lancet Gastroenterol Hepatol. 2025 Oct;10(10):941-951. doi: 10.1016/S2468-1253(25)00053-6. Epub 2025 Jul 23. Lancet Gastroenterol Hepatol. 2025. PMID: 40714040 Free PMC article. Review.
97 results